Discover trends, market shifts, and competitive outlooks for the parathyroid hormone industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Is the Current and Projected Market Size of the Parathyroid Hormone Market Through 2034?#_x000D_

In recent times, there has been a consistent expansion of the parathyroid hormone market. It is projected to increase from $2.35 billion in 2024 to about $2.43 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.5%. Factors contributing to the growth in the past include the increasing incidences of chronic kidney disease, a heightened awareness of disorders associated with the parathyroid hormone, an escalating demand for parathyroid hormone analogs, generous government funding for research into the parathyroid hormone, and increased disposable income._x000D_

_x000D_

In the next few years, the market size for parathyroid hormone is predicted to experience significant growth, potentially reaching $3.5 billion in 2029 with a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this upward trajectory during the prediction period include a rising elderly population, private healthcare sector expansion, emerging indications, precision medicine, increased consciousness of bone health, and wider healthcare accessibility. Key trends anticipated during this period encompass developments in parathyroid hormone testing, improved drug delivery methods, combination therapies, digital health integration, as well as sustainability and green initiatives._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the Parathyroid Hormone Market?#_x000D_

The augmentation in osteoporosis occurrence is likely to propel the parathyroid hormone market. Identified by reduced bone mass and decay of bone tissue, osteoporosis significantly heightens the fracture risk. For example, as per data from the International Osteoporosis Foundation in January 2023, approximately 1.4 million Canadians, primarily postmenopausal women and the elderly, suffer from osteoporosis. The parathyroid hormone, a naturally produced substance in the human body that controls calcium levels, is employed to minimize fracture risk in osteoporosis patients through daily subcutaneous injections. Hence, the rising instances of osteoporosis are anticipated to fuel the parathyroid hormone market’s expansion._x000D_

_x000D_

#How Is the Parathyroid Hormone Market Segmented?#_x000D_

The parathyroid hormone market covered in this report is segmented –_x000D_

_x000D_

1) By Disease Type: Hypocalcemia, Hypoparathyroidism_x000D_

2) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues_x000D_

3) By End-User: Hospitals, Clinics, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Hypocalcemia: Pseudohypoparathyroidism, Vitamin D Deficiency_x000D_

2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism, Idiopathic Hypoparathyroidism_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3427&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Parathyroid Hormone Market Growth?#_x000D_

The countries covered in the parathyroid hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the Parathyroid Hormone Industry?#_x000D_

Parathyroid hormone market’s dominant firms are concentrating on the creation of biosimilars, such as parathyroid hormone (PTH) prodrugs. These biosimilars have the potential to augment treatment alternatives. A PTH prodrug is a non-active substance that changes into an active parathyroid hormone following administration, providing a sustained release and consistent therapeutic effects for bone health and calcium regulation. For example, Ascendis Pharma A/S, a biopharmaceutical corporation based in Denmark, announced in August 2024 that the Food & Drug Administration (FDA) had given its approval for YORVIPATH (palopegteriparatide) — the first-ever hypoparathyroidism therapy for adults. This prodrug, administered once daily, provides steady PTH exposure, benefiting an estimated 70,000 to 90,000 patients across the US. Ascendis Pharma offers patient assistance via its ascendis signature access program (A.S.A.P), however, patients must consistently monitor their serum calcium levels to guard against potential hypercalcemia or hypocalcemia._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report_x000D_

_x000D_

#How Is the Parathyroid Hormone Market Defined and What Are Its Core Parameters?#_x000D_

Parathyroid hormone refers to a substance produced by the parathyroid gland that aids in the body’s storage and utilization of calcium. High blood calcium levels are a result of parathyroid hormone levels that are greater than usual and could be a disease indicator. It is also known as PTH, parathyrin, and parathormone._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3427_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model